Special airway concerns in patients with mucopolysaccharidoses

H Steven Sims1, James J Kempiners

  • 1Chicago Institute for Voice Care, University of Illinois at Chicago, IL 60612, USA. voicecare@uic.edu

Respiratory Medicine
|April 7, 2007
PubMed

Insights

Mucopolysaccharidoses are rare genetic disorders affecting mucopolysaccharide breakdown. Managing airway complications in these patients requires careful decision-making due to potential respiratory issues.

Area of Science:

  • Medical Genetics
  • Biochemistry
  • Pulmonology

Background:

  • Mucopolysaccharidoses (MPS) are a group of rare inherited metabolic disorders.
  • These conditions result from deficiencies in enzymes responsible for degrading mucopolysaccharides (glycosaminoglycans).
  • Accumulation of mucopolysaccharides leads to progressive cellular damage affecting multiple organ systems.

Observation:

  • Patients with MPS often present with complex airway challenges.
  • Respiratory pathology, including upper and lower airway obstruction, is a significant concern.
  • Despite increased lifespan, airway management remains a critical aspect of patient care.

Findings:

  • This report details two cases highlighting the complexities of airway management in MPS patients.
  • Effective airway management necessitates informed decision-making and tailored strategies.
  • Early recognition and intervention for respiratory compromise are crucial.

Implications:

  • These cases underscore the importance of specialized knowledge for managing MPS-related airway issues.
  • Improved understanding can lead to better clinical protocols and patient outcomes.
  • Further research into airway management techniques for MPS is warranted.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Assessment of Airway, Skin Color, and Use of Accessory Muscles01:30

Assessment of Airway, Skin Color, and Use of Accessory Muscles

A thorough assessment of respiratory health is paramount in clinical settings to identify and manage respiratory distress and ensure adequate oxygenation. This article elaborates on the critical aspects of respiratory evaluation, including airway assessment, skin color examination, and the observation of accessory muscle use, which are integral to effectively diagnosing and managing patients with respiratory conditions.
Introduction
The initial evaluation of a patient's respiratory system...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques01:30

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway interventions are...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...